Peripheral T-Cell Lymphoma, Not Otherwise Specified

Peripheral T-Cell Lymphoma, Not Otherwise Specified — Trials · CancerIndex

Clinical trials

Registered studies

299 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 72
Recruiting: 44
Ph III recruiting: 7
Growth YoY: —
Industry share: 22%
Top sponsor: City of Hope Medical Center
Termination share: 29.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (41)

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07746245	The Efficacy of CAPCT in Patients With PTCL	not yet recruiting	Phase 2	58	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	1	Aug 5, 2026	clinicaltrials
NCT07706959	New Genotype-guided Treatment in Newly Diagnosed PTCL(G08)	not yet recruiting	Phase 1 / Phase 2	108	Ruijin HospitalOTHER	1	Jul 16, 2026	clinicaltrials